Back to top
more

Dentsply Sirona (XRAY)

(Delayed Data from NSDQ)

$25.00 USD

25.00
2,944,689

-1.12 (-4.29%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $25.01 +0.01 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (170 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Bet on Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.

BD Introduces New Product to Reduce the Risk of Sepsis

by Zacks Equity Research

BD introduces new FDA cleared product to lower the risk of sepsis and combat platelet contamination.

Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now

by Zacks Equity Research

Strong prospects in emerging markets provide DENTSPLY (XRAY) a competitive edge in the MedTech space.

XRAY vs. CNMD: Which Stock Is the Better Value Option?

by Zacks Equity Research

XRAY vs. CNMD: Which Stock Is the Better Value Option?

Dentsply (XRAY) Up 18.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Top Ranked Momentum Stocks to Buy for March 21st

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 21st

XRAY vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

XRAY vs. CNMD: Which Stock Is the Better Value Option?

Will DENTSPLY SIRONA Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA.

DENTSPLY's (XRAY) Preliminary Q4 Results Cheer Investors

by Zacks Equity Research

DENTSPLY (XRAY) expects to see solid performance in Europe and the rest of the world.

Will R&D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) overall growth strategy depends on product innovation and R&D focus, which is likely to drive the top line in Q4.

Earnings Preview: Dentsply International (XRAY) Q4 Earnings Expected to Decline

by Zacks Equity Research

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Near-Term Outlook for Dental Supplies Industry Looks Bright

by Zacks Equity Research

The wave of digital transformation is shaping the future of dental supply companies.

Here's Why Investors Should Hold DENTSPLY (XRAY) Stock Now

by Zacks Equity Research

DENTSPLY (XRAY) gains from strength in CAD/CAM dental imaging platform. However, sluggishness in the European business is worrisome.

Why Is Dentsply (XRAY) Down 1.3% Since Last Earnings Report?

by Zacks Equity Research

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for December 7th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates

by Zacks Equity Research

DENTSPLY SIRONA (XRAY) witnesses dismal segmental performance in Q3; 2018 guidance lowered.

Dentsply International (XRAY) Lags Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Dentsply (XRAY) delivered earnings and revenue surprises of -15.56% and -2.56%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

BioLife (BLFS) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

BioLife (BLFS) is likely to gain from solid segmental revenues in Q3.

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can R&D Focus Drive DENTSPLY SIRONA's (XRAY) Q3 Earnings?

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) focus on R&D and strategic buyouts to drive Q2 results.

DENTSPLY Launches Azento, Improves Digital Implant Workflow

by Zacks Equity Research

DENTSPLY's (XRAY) Azento is a unique dental platform that will help dentists select the best-fitting implant, optimal implant positioning and feasible healing environment.

    Dentsply (XRAY) Down 2.3% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      PDCO or XRAY: Which Is the Better Value Stock Right Now?

      by Zacks Equity Research

      PDCO vs. XRAY: Which Stock Is the Better Value Option?

        Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now

        by Zacks Equity Research

        DENTSPLY (XRAY) incurs goodwill and intangible impairment charge. A lowered guidance is a concern.

          DENTSPLY (XRAY) Beats on Q2 Earnings, Lowers 2018 Guidance

          by Zacks Equity Research

          DENTSPLY (XRAY) gains from solid year-over-year international revenue growth in Q2; high impairment charges in the quarter mars results.